SIM
ACOR

Spark Investment Management’s Acorda Therapeutics ACOR Stock Holding History

Spark Investment Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-919
Closed -$102K – 318
2020
Q1 		$102K Hold
919
– – 0.05% 277
2019
Q4 		$225K Buy
+919
New +$232K 0.03% 442
2019
Q3 		– Sell
-334
Closed -$307K – 544
2019
Q2 		$307K Sell
334
-2,684
-89% -$3.3M 0.02% 421
2019
Q1 		$4.81M Sell
3,018
-393
-12% -$708K 0.22% 126
2018
Q4 		$6.38M Buy
3,411
+741
+28% +$1.61M 0.44% 68
2018
Q3 		$6.29M Sell
2,670
-755
-22% -$2.34M 0.36% 71
2018
Q2 		$11.8M Sell
3,425
-847
-20% -$2.59M 0.69% 24
2018
Q1 		$12.1M Buy
4,272
+863
+25% +$2.58M 0.77% 21
2017
Q4 		$8.78M Sell
3,409
-404
-11% -$1.15M 0.47% 48
2017
Q3 		$10.8M Buy
3,813
+199
+6% +$524K 0.58% 27
2017
Q2 		$8.54M Buy
3,614
+2,008
+125% +$3.98M 0.53% 37
2017
Q1 		$4.05M Sell
1,606
-1,127
-41% -$3.24M 0.26% 110
2016
Q4 		$6.16M Buy
2,733
+296
+12% +$704K 0.51% 38
2016
Q3 		$6.11M Hold
2,437
– – 0.49% 34
2016
Q2 		$7.46M Buy
2,437
+201
+9% +$654K 0.7% 10
2016
Q1 		$7.1M Buy
2,236
+1,165
+109% +$4.84M 0.72% 11
2015
Q4 		$5.5M Buy
1,071
+172
+19% +$752K 0.7% 17
2015
Q3 		$2.86M Hold
899
– – 0.37% 67
2015
Q2 		$3.6M Buy
899
+159
+21% +$614K 0.5% 34
2015
Q1 		$2.96M Hold
740
– – 0.41% 54
2014
Q4 		$3.63M Sell
740
-216
-23% -$927K 0.61% 26
2014
Q3 		$3.89M Sell
956
-222
-19% -$833K 0.58% 29
2014
Q2 		$4.76M Buy
1,178
+602
+105% +$2.45M 0.71% 14
2014
Q1 		$2.62M Sell
576
-104
-15% -$420K 0.41% 59
2013
Q4 		$2.38M Buy
680
+117
+21% +$456K 0.41% 52
2013
Q3 		$2.31M Sell
563
-40
-7% -$172K 0.53% 33
2013
Q2 		$2.38M Buy
+603
New +$2.48M 0.64% 31

Other funds holding ACOR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Spark Investment Management's ACOR Position: Q2 2020 in Review

Spark Investment Management sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 919 shares — an estimated $102K sold.

Spark Investment Management first reported a position in ACOR in Q2 2013 and held it in 27 quarters. The position peaked at $12.1M in Q1 2018. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

  • Spark Investment Management reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 919 Acorda Therapeutics shares in Q2 2020, an estimated $102K.
  • Spark Investment Management first reported a position in Acorda Therapeutics in Q2 2013 and held it in 27 quarters.
  • Spark Investment Management's Acorda Therapeutics position peaked at $12.1M in Q1 2018.
  • 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.